As Microsoft (MSFT) Share Value Rose, Shareholder Bank Hapoalim Bm Has Boosted Its Position; Capital Planning Advisors Has Boosted Stake in Celgene (CELG) by $348,435

August 12, 2018 - By Megan Stone

Celgene Corporation (NASDAQ:CELG) Logo

Capital Planning Advisors Llc increased its stake in Celgene Corp (CELG) by 105.3% based on its latest 2018Q1 regulatory filing with the SEC. Capital Planning Advisors Llc bought 3,915 shares as the company’s stock declined 18.51% with the market. The hedge fund held 7,633 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $681,000, up from 3,718 at the end of the previous reported quarter. Capital Planning Advisors Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $64.15B market cap company. The stock decreased 0.77% or $0.71 during the last trading session, reaching $91.21. About 3.25M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 32.65% since August 12, 2017 and is downtrending. It has underperformed by 45.22% the S&P500. Some Historical CELG News: 04/05/2018 – Celgene Now Sees 2018 Adjusted EPS About $8.95 Ex-June Dilution; 24/05/2018 – FMI,MRK IN COLLABORATION PACT FOR KEYTRUDA COMPANION DIAGNOSTIC; 13/04/2018 – BRISTOL-MYERS SQUIBB- IN TRIAL, TWO SECONDARY ENDPOINTS OF ORR, MEDIAN DURATION OF RESPONSE DEMONSTRATED DURABILITY WITH OPDIVO VS DOCETAXEL; 08/03/2018 – Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite St; 06/04/2018 – Hagens Berman Alerts Investors in Celgene Corporation to the May 29, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action and to the Abrupt Departure of Celgene’s President; 17/05/2018 – Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination T; 17/05/2018 – Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck; 19/04/2018 – Celgene: Hans Bishop Elected to Bd of Directors; 14/05/2018 – HHS Secretary Azar talks about more brass knuckle tactics on drug prices, but investors shrug it off again $CELG +1%; 04/05/2018 – Celgene Delivers No-Drama Quarter Following Series of Setbacks

Bank Hapoalim Bm increased its stake in Microsoft Corp (MSFT) by 116.68% based on its latest 2018Q1 regulatory filing with the SEC. Bank Hapoalim Bm bought 16,113 shares as the company’s stock rose 3.08% while stock markets declined. The institutional investor held 29,922 shares of the prepackaged software company at the end of 2018Q1, valued at $2.73M, up from 13,809 at the end of the previous reported quarter. Bank Hapoalim Bm who had been investing in Microsoft Corp for a number of months, seems to be bullish on the $835.84B market cap company. The stock decreased 0.61% or $0.67 during the last trading session, reaching $109. About 14.51M shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 41.28% since August 12, 2017 and is uptrending. It has outperformed by 28.71% the S&P500. Some Historical MSFT News: 14/05/2018 – Smartsheet to Announce First Quarter FY19 Earnings on June 4, 2018; 26/04/2018 – MSFT Filings: Microsoft Corp 10-Q Filed On 2018-04-26; 06/04/2018 – Dutch Fund Sells Apple, Microsoft, Costco, AT&T — Barrons.com; 19/03/2018 – MSFT: IMPROVED MULTI-MEMBER BLOCKCHAIN NETWORKS NOW ON AZURE; 04/04/2018 – Microsoft announces quarterly earnings release date; 15/05/2018 – Microsoft and Kymeta Government Solutions Demonstrate Defense and First Responder On-the-Move Communications Solutions; 23/05/2018 – Simulations Plus Releases GastroPlus™ Version 9.6; 21/03/2018 – U.S. spending bill includes bid to solve international email privacy impasse; 05/04/2018 – Agio Launches New Public Cloud and Cybersecurity Offering: SkySuite; 25/04/2018 – 2018 Vizient Connections Summit to Focus on Maximizing Supply Chain Operations and Pharmacy Performance

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 21 have Buy rating, 1 Sell and 13 Hold. Therefore 60% are positive. Celgene Corporation had 153 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co with “Buy” on Friday, August 4. The firm earned “Underweight” rating on Monday, October 23 by Morgan Stanley. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, June 23 by Jefferies. BMO Capital Markets maintained the shares of CELG in report on Friday, July 28 with “Outperform” rating. The firm earned “Equal-Weight” rating on Friday, October 13 by Barclays Capital. Guggenheim maintained Celgene Corporation (NASDAQ:CELG) rating on Thursday, December 21. Guggenheim has “Buy” rating and $152.0 target. The stock has “Outperform” rating by Credit Suisse on Wednesday, January 20. On Friday, June 30 the stock rating was downgraded by BTIG Research to “Neutral”. The firm has “Neutral” rating given on Friday, October 27 by Citigroup. Credit Suisse maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, January 8. Credit Suisse has “Buy” rating and $125.0 target.

Capital Planning Advisors Llc, which manages about $180.00 million and $281.69 million US Long portfolio, decreased its stake in Bristol Myers Squibb Co (NYSE:BMY) by 5,916 shares to 29,450 shares, valued at $1.86M in 2018Q1, according to the filing. It also reduced its holding in Vanguard Index Fds (VTV) by 8,461 shares in the quarter, leaving it with 100,798 shares, and cut its stake in Alphabet Inc.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Fool.com which released: “3 Top Value Stocks to Buy Right Now” on August 11, 2018, also Nasdaq.com with their article: “Celgene (CELG) Q2 Earnings: Disappointment in Store?” published on July 23, 2018, Benzinga.com published: “Celgene Q2 Earnings Preview” on July 25, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Benzinga.com and their article: “Inspired By Tesla: RBC Speculates On Go-Private Scenario For Celgene” published on August 09, 2018 as well as Investorplace.com‘s news article titled: “5 Top Stock Trades for Friday — Buy Yelp, Roku After Earnings Surge?” with publication date: August 09, 2018.

Since February 15, 2018, it had 1 buy, and 5 insider sales for $6.21 million activity. LOUGHLIN JAMES J also sold $1.40 million worth of Celgene Corporation (NASDAQ:CELG) shares. Shares for $1.77 million were sold by KAPLAN GILLA on Thursday, February 15. On Tuesday, May 8 Alles Mark J bought $99,784 worth of Celgene Corporation (NASDAQ:CELG) or 1,208 shares. MARIO ERNEST sold $1.26M worth of stock.

Investors sentiment decreased to 0.79 in 2018 Q1. Its down 0.04, from 0.83 in 2017Q4. It is negative, as 120 investors sold CELG shares while 470 reduced holdings. 106 funds opened positions while 363 raised stakes. 513.18 million shares or 8.59% less from 561.38 million shares in 2017Q4 were reported. Stonebridge Cap Advsr Limited Co owns 0.27% invested in Celgene Corporation (NASDAQ:CELG) for 13,242 shares. Daiwa Gp owns 75,457 shares for 0.05% of their portfolio. North Star Mgmt Corporation invested in 26,470 shares or 0.28% of the stock. Sumitomo Mitsui Tru Holdings reported 2.38M shares. 20,047 were reported by Condor Capital Management. Spears Abacus Advsr Ltd Llc holds 2.28% or 196,617 shares. Gamco Investors Et Al owns 3,100 shares. Boys Arnold Inc owns 14,982 shares. Sio Cap Mngmt Ltd Liability has 1.67% invested in Celgene Corporation (NASDAQ:CELG). Century Cos Inc holds 0.39% in Celgene Corporation (NASDAQ:CELG) or 4.32M shares. Checchi Capital Advisers Ltd Liability owns 6,405 shares or 0.08% of their US portfolio. Altfest L J & stated it has 5,541 shares or 0.21% of all its holdings. 292,344 were reported by Welch And Forbes Limited Liability. California Public Employees Retirement Systems holds 0.24% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 1.90 million shares. Lmr Partners Llp owns 9,026 shares.

Investors sentiment decreased to 0.74 in Q1 2018. Its down 0.03, from 0.77 in 2017Q4. It fall, as 49 investors sold MSFT shares while 1035 reduced holdings. 142 funds opened positions while 665 raised stakes. 5.38 billion shares or 1.45% less from 5.46 billion shares in 2017Q4 were reported. Amg Natl Trust Bancorp has 0.09% invested in Microsoft Corporation (NASDAQ:MSFT). Timessquare Cap Ltd Llc holds 0.09% or 143,050 shares in its portfolio. Karpus Inc holds 4,822 shares or 0.02% of its portfolio. Boyer Corporon Wealth Mgmt Limited Liability Corp reported 1.63% stake. Westwood Gru has invested 1.01% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Logan has 195,944 shares. Loudon Mngmt Limited Liability Co stated it has 3.84% in Microsoft Corporation (NASDAQ:MSFT). Pinnacle Advisory Group owns 14,222 shares or 0.08% of their US portfolio. Bangor Natl Bank accumulated 16,475 shares. Penobscot Invest Mngmt invested in 2.27% or 103,605 shares. Alpine Woods Capital Investors Limited Company has 157,900 shares. Pub Employees Retirement Of Ohio invested in 5.43M shares or 2.58% of the stock. 55,456 were reported by Spc. Chevy Chase Hldgs Inc has invested 3.14% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Artisan Prns Partnership reported 0.53% of its portfolio in Microsoft Corporation (NASDAQ:MSFT).

Since February 16, 2018, it had 1 insider purchase, and 4 selling transactions for $1.39 million activity. PETERSON SANDRA E also bought $550,606 worth of Microsoft Corporation (NASDAQ:MSFT) shares.

Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 32 have Buy rating, 1 Sell and 4 Hold. Therefore 86% are positive. Microsoft Corporation had 208 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Buy” rating given on Monday, August 21 by Stifel Nicolaus. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Buy” rating given on Wednesday, August 23 by BMO Capital Markets. Bank of America maintained the stock with “Buy” rating in Wednesday, June 14 report. Piper Jaffray maintained it with “Buy” rating and $9000 target in Friday, July 21 report. The stock has “Buy” rating by UBS on Monday, August 29. FBN Securities maintained the stock with “Outperform” rating in Wednesday, July 20 report. Vetr upgraded the shares of MSFT in report on Wednesday, September 2 to “Strong-Buy” rating. On Friday, April 27 the stock rating was maintained by Barclays Capital with “Overweight”. The firm has “Buy” rating given on Wednesday, June 13 by UBS. The rating was upgraded by Tigress Financial on Monday, January 23 to “Buy”.

Bank Hapoalim Bm, which manages about $385.86 million US Long portfolio, decreased its stake in Powershares Qqq Trust (QQQ) by 4,616 shares to 37,521 shares, valued at $6.01M in 2018Q1, according to the filing. It also reduced its holding in Wisdomtree Europe Hed Eq Fd (HEDJ) by 20,871 shares in the quarter, leaving it with 37,045 shares, and cut its stake in Ishares Tr (Prn) (IEI).

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Benzinga.com which released: “It’s Hard To Find Problems With Microsoft’s Q4 Earnings: The Street Weighs In” on July 20, 2018, also Seekingalpha.com with their article: “I Was Wrong About Microsoft: It’s A Buy” published on July 31, 2018, Nasdaq.com published: “Microsoft (MSFT) Slips 0.78% Ahead of Earnings: What To Watch” on July 18, 2018. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Seekingalpha.com and their article: “Microsoft Soaring To All-Time Highs” published on July 26, 2018 as well as Seekingalpha.com‘s news article titled: “Sell Microsoft And Don’t Look Back” with publication date: August 08, 2018.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts